Created in 2007 (Germany), ATUPLEX own 4 sister brands and 2214 competing brands. The ATUPLEX brand is owned by Silence Therapeutics plc, a company listed in Etats-Unis. The International Securities Identification Number (ISIN) of Silence Therapeutics plc is GB00B9GTXM62. ATUPLEX belongs to the Biotechnology business sector.

ATUPLEX is a brand of Silence Therapeutics plc (SLNCF) Share price

International deposit : 2007 Business sector Biotechnology

Share price and profitability of the share Silence Therapeutics plc (ATUPLEX)

Buy Silence Therapeutics plc share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 8.00

Portfolio valuation
Silence Therapeutics plc (ATUPLEX) over 5 years* USD 67.37

Stock market history Silence Therapeutics plc (ATUPLEX)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Silence Therapeutics plc

See more brands of Silence Therapeutics plc

Rival brands
ATUPLEX

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS